Redhill Biopharma Ltd. Share Price
NASDAQ: RDHL$0.39
+$0.39 (--%) Last updated on 29 Oct, 2026 | 19:36 ISTRedhill Biopharma Ltd. Stock Performance
Redhill Biopharma Ltd. Share Price Chart
$0.39$0.40
L
H
About Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
Redhill Biopharma Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.47 | $0.39 | -26.63% |
Sep 2026 | $0.83 | $0.54 | -14.63% |
Aug 2026 | $0.61 | $0.63 | -8.84% |
Jul 2026 | $0.80 | $0.69 | -21.14% |
Jun 2026 | $0.99 | $0.88 | -17.84% |
May 2026 | $1.07 | $1.06 | -2.74% |
Apr 2026 | $0.82 | $1.09 | +46.00% |
Mar 2026 | $0.90 | $0.75 | -22.68% |
Feb 2026 | $1.08 | $0.97 | -20.49% |
Jan 2026 | $1.04 | $1.22 | +18.45% |
Dec 2025 | $1.22 | $1.03 | -13.45% |
Nov 2025 | $1.28 | $1.19 | -9.16% |